64485-82-1Relevant articles and documents
Synthetic method for ceftazidime side chain acid ethyl ester
-
Paragraph 0047; 0049; 0050; 0052; 0054; 0055; 0057; 0059, (2020/03/06)
The invention belongs to the technical field of medicine, and particularly relates to a synthetic method for ceftazidime side chain acid ethyl ester. The method comprises the following steps: adding sodium nitrite and ethyl acetoacetate into water, adding acetic acid for a reaction, performing extraction, and collecting the organic phase; performing distillation on the collected organic phase under normal and reduced pressure to obtain an oxime compound, performing dehydration treatment on the oxime compound, adding an alcohol, a catalyst and chlorine gas, and performing a chlorination reaction to obtain a chloride; performing a reaction on methanol, thiourea, a phase transfer catalyst, a buffer salt solution and the chloride to obtain an ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate solution; and performing distillation on the ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate solution under reduced pressure to obtain ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate solution and a buffer salt, adding tert-butyl 2-bromoisobutyrate, a condensation catalyst and a solvent, and performing a reaction to obtain the ceftazidime side chain acid ethyl ester. The method is moreefficient, simpler, and more environmentally friendly and has higher quality and yield than a previous processes, and is suitable for large-scale industrial production.
7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporins
-
, (2008/06/13)
A 7-[2-(2-aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporin derivative of the formula; STR1 wherein R3 is hydrogen or a residue of a nucleophilic compound; R2 NH is an amino group which may optionally be protected, pharmaceutically acceptable salt or ester thereof, is found to have excellent anti-bacterial activity against a broad spectrum of bacteria inclusive of gram-negative bacteria such as Escherichia coli, Serratia marcescens, Proteus rettgeri, Enterobacter cloacae and Citrobacter freundii. Thus, this compound may be used for an antibacterial agent in therapeutical purposes.
(6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereof
-
, (2008/06/13)
Cephalosporin antibiotics of the general formula STR1 (wherein Ra and Rb, which may be the same or different, each represent a C1-4 alkyl group or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkylidene group; and R4 represents hydrogen or a 3- or 4-carbamoyl group) exhibit broad spectrum antibiotic activity, the activity being unusually high against gram-negative organisms such as strains of Pseudomonas organisms. A particular antibiotic compound of formula (I) possessing excellent antibacterial activity against strains of Pseudomonas organisms, as well as other valuable therapeutic properties, is (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimono) acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4 carboxylate. The invention also includes the non-toxic salts and non-toxic metabolically labile esters of compounds of formula (I). Also described are compositions containing the antibiotics of the invention and processes for the preparation of such antibiotics.